IN8bio, Inc.
NASDAQ:INAB
0.2802 (USD) • At close January 2, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q2 | 2018 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 0 | 0 | 0 | 3.748 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 0 | 0.631 | 0.632 | 0.627 | 0.647 | 0.637 | 0.59 | 0.351 | 0.246 | 0.274 | 0.232 | 0.089 | 0.057 | 0 | 0.165 | 0 | 0.022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| 0 | -0.631 | -0.632 | 3.121 | -0.647 | -0.637 | -0.59 | -0.351 | -0.246 | -0.274 | -0.232 | -0.089 | -0.057 | 0 | -0.165 | 0 | -0.022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit Ratio
| 0 | 0 | 0 | 0.833 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 3.309 | 5.156 | 4.903 | 4.522 | 3.786 | 4.134 | 4.385 | 3.922 | 4.255 | 3.504 | 2.381 | 2.687 | 1.35 | 2.064 | 1.245 | 1.485 | 1.057 | 1.784 | 1.052 | 0.715 | 0.715 | 0.464 | 0.464 | 0.145 | 0.145 |
General & Administrative Expenses
| 2.732 | 3.533 | 3.742 | 3.076 | 3.383 | 3.581 | 3.47 | 3.876 | 3.144 | 3.675 | 3.764 | 3.162 | 2.041 | 0.986 | 1.118 | 0.826 | 0.624 | 1.09 | 0.639 | 0.638 | 0.638 | 0.716 | 0.716 | 0.356 | 0.356 |
Selling & Marketing Expenses
| 0 | 0 | 0 | -0.627 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 2.732 | 3.533 | 3.742 | 2.449 | 3.383 | 3.581 | 3.47 | 3.876 | 3.144 | 3.675 | 3.764 | 3.162 | 2.041 | 0.986 | 1.118 | 0.826 | 0.624 | 1.09 | 0.639 | 0.638 | 0.638 | 0.716 | 0.716 | 0.356 | 0.356 |
Other Expenses
| 1.045 | -0.06 | 0 | 0.33 | 0 | 0 | -0.33 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.533 | -2.533 | -1.002 | -1.002 |
Operating Expenses
| 7.086 | 8.629 | 8.645 | 6.971 | 7.169 | 7.715 | 7.525 | 7.798 | 7.399 | 7.179 | 6.145 | 5.849 | 3.391 | 3.05 | 2.363 | 2.311 | 1.681 | 2.874 | 1.691 | 1.354 | 1.354 | 1.214 | 1.214 | -0.501 | -0.501 |
Operating Income
| -7.086 | -8.629 | -8.562 | -7.598 | -7.169 | -7.715 | -7.525 | -7.798 | -7.399 | -7.179 | -6.145 | -5.849 | -3.391 | -3.05 | -2.363 | -2.311 | -1.681 | -2.874 | -1.691 | -1.353 | -1.353 | -1.18 | -1.18 | -0.501 | -0.501 |
Operating Income Ratio
| 0 | 0 | 0 | -2.027 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| 0 | 0 | 0 | 0.33 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.001 | -0.001 | -0.034 | -0.034 | -0.019 | -0.019 |
Income Before Tax
| -7.086 | -8.629 | -8.562 | -7.598 | -7.169 | -7.715 | -7.525 | -7.798 | -7.399 | -7.179 | -6.145 | -5.849 | -3.391 | -3.05 | -2.363 | -2.311 | -1.681 | -2.874 | -1.691 | -1.354 | -1.354 | -1.214 | -1.214 | -0.52 | -0.52 |
Income Before Tax Ratio
| 0 | 0 | 0 | -2.027 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| 0 | 0 | -0.632 | -7.598 | -0.647 | 0.515 | -0.59 | 0.296 | 0.219 | 0 | 0 | 0.145 | 0.142 | -0.715 | 0 | 0 | 0 | 0 | 0 | 0.196 | 0.196 | -0.017 | -0.017 | -0.016 | -0.016 |
Net Income
| -7.086 | -8.629 | -8.562 | -7.598 | -7.169 | -7.715 | -6.935 | -7.798 | -7.399 | -7.179 | -6.145 | -5.849 | -3.391 | -3.05 | -2.363 | -2.311 | -1.681 | -2.874 | -1.691 | -1.55 | -1.55 | -1.407 | -1.407 | -0.52 | -0.52 |
Net Income Ratio
| 0 | 0 | 0 | -2.027 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS
| -0.15 | -0.19 | -0.2 | -0.21 | -0.23 | -0.27 | -0.28 | -0.32 | -0.34 | -0.38 | -0.33 | -0.44 | -0.25 | -0.16 | -0.16 | -0.12 | -0.087 | -0.19 | -0.11 | -0.48 | -0.48 | -0.16 | -0.16 | -0.084 | -0.084 |
EPS Diluted
| -0.15 | -0.19 | -0.2 | -0.21 | -0.23 | -0.27 | -0.28 | -0.32 | -0.34 | -0.38 | -0.33 | -0.44 | -0.25 | -0.16 | -0.16 | -0.12 | -0.087 | -0.19 | -0.11 | -0.48 | -0.48 | -0.16 | -0.16 | -0.084 | -0.084 |
EBITDA
| -5.351 | -7.998 | -8.013 | -7.301 | -6.522 | -7.078 | -6.935 | -7.447 | -7.153 | -6.905 | -5.913 | -5.76 | -3.334 | -2.86 | -2.198 | -2.289 | -1.659 | -2.852 | -1.669 | -1.33 | -1.33 | -1.155 | -1.155 | -0.493 | -0.493 |
EBITDA Ratio
| 0 | 0 | 0 | -1.86 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |